RxDoctor Payments Data

Beatriz Colon

Emergency Medicine · Orlando, FLNPI 1457313496

Payments from drug & device makers

What this record shows

Alnylam Pharmaceuticals Inc. accounts for 78.8% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2023 at $1,244 and has fallen 75.0% since, to $311 in 2025. Among emergency medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,580in general payments, 2019–2025

Across 15 payments — averaging $105.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alnylam Pharmaceuticals Inc.$1K
  • Bayer$311
  • Genentech USA, Inc.$25
$1,830,559in research payments, 2019–2025

Across 97 payments — averaging $18,872 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • E.r. Squibb & Sons, L.L.C.$722K
  • Genentech, Inc.$598K
  • AstraZeneca$224K
  • Madrigal Pharmaceuticals$84K
  • Hoffmann-la Roche Limited$79K
  • Boehringer Ingelheim International GmbH$57K
  • plus $67K from 5 others

What the payments were for

  • Travel & lodging$92659%
  • Food & beverage$65341%

General payments by program year

20
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Alnylam Pharmaceuticals Inc.9$1,244
Bayer5$311
Genentech USA, Inc.1$25

How this compares

$1,580 in reported general payments places this provider in the 95th percentile of 3,289 emergency medicine providers in Florida.

See all emergency medicine providers in Florida

Other emergency medicine in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →